Aster Capital Management (Difc) LTD Amylyx Pharmaceuticals, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 3,568 shares of AMLX stock, worth $45,242. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,568Holding current value
$45,242% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
156Shares Held
77.7MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$112 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$100 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$75.4 Million7.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.27MShares$66.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$57.5 Million0.07% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $742M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...